177 related articles for article (PubMed ID: 12148742)
1. On cold spots in tumor subvolumes.
Tomé WA; Fowler JF
Med Phys; 2002 Jul; 29(7):1590-8. PubMed ID: 12148742
[TBL] [Abstract][Full Text] [Related]
2. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data.
Levegrün S; Jackson A; Zelefsky MJ; Skwarchuk MW; Venkatraman ES; Schlegel W; Fuks Z; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1064-80. PubMed ID: 11704332
[TBL] [Abstract][Full Text] [Related]
3. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
Balderson MJ; Kirkby C
Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
[TBL] [Abstract][Full Text] [Related]
4. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
Mavroidis P; Ferreira BC; Lopes Mdo C
Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
[TBL] [Abstract][Full Text] [Related]
5. A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning.
Jin JY; Kong FM; Liu D; Ren L; Li H; Zhong H; Movsas B; Chetty IJ
Med Phys; 2011 Jan; 38(1):439-48. PubMed ID: 21361212
[TBL] [Abstract][Full Text] [Related]
6. Equivalent uniform dose concept evaluated by theoretical dose volume histograms for thoracic irradiation.
Dumas JL; Lorchel F; Perrot Y; Aletti P; Noel A; Wolf D; Courvoisier P; Bosset JF
Phys Med; 2007 Mar; 23(1):16-24. PubMed ID: 17568539
[TBL] [Abstract][Full Text] [Related]
7. Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.
Selvaraj J; Uzan J; Baker C; Nahum A
Med Phys; 2013 Apr; 40(4):041715. PubMed ID: 23556885
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
Chan MKH; Chiang CL
Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
[TBL] [Abstract][Full Text] [Related]
9. Selective boosting of tumor subvolumes.
Tomé WA; Fowler JF
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):593-9. PubMed ID: 10974480
[TBL] [Abstract][Full Text] [Related]
10. The delta-TCP concept: a clinically useful measure of tumor control probability.
Sanchez-Nieto B; Nahum AE
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):369-80. PubMed ID: 10760433
[TBL] [Abstract][Full Text] [Related]
11. A role for biological optimization within the current treatment planning paradigm.
Das S
Med Phys; 2009 Oct; 36(10):4672-82. PubMed ID: 19928099
[TBL] [Abstract][Full Text] [Related]
12. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
Appenzoller LM; Michalski JM; Thorstad WL; Mutic S; Moore KL
Med Phys; 2012 Dec; 39(12):7446-61. PubMed ID: 23231294
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study.
Duan J; Shen S; Fiveash JB; Popple RA; Brezovich IA
Med Phys; 2006 May; 33(5):1380-7. PubMed ID: 16752574
[TBL] [Abstract][Full Text] [Related]
14. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
D'Souza WD; Thames HD; Kuban DA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
[TBL] [Abstract][Full Text] [Related]
15. Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes.
Kim Y; Tomé WA
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1528-42. PubMed ID: 17126211
[TBL] [Abstract][Full Text] [Related]
16. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
Gordon JJ; Sayah N; Weiss E; Siebers JV
Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
[TBL] [Abstract][Full Text] [Related]
17. The theoretical benefit of beam fringe compensation and field size reduction for iso-normal tissue complication probability dose escalation in radiotherapy of lung cancer.
Engelsman M; Remeijer P; van Herk M; Mijnheer B; Damen E
Med Phys; 2003 Jun; 30(6):1086-95. PubMed ID: 12852532
[TBL] [Abstract][Full Text] [Related]
18. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
19. Inclusion of geometric uncertainties in treatment plan evaluation.
van Herk M; Remeijer P; Lebesque JV
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1407-22. PubMed ID: 11955756
[TBL] [Abstract][Full Text] [Related]
20. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
Ruggieri R; Nahum AE
Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
